Clinical Trial Update: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the anti-atherosclerotic effect of torcetrapib/atorvastatin versus atorvastatin in mixed hyperlipidemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Torcetrapib (torcetrapib)
• Torcetrapib/atorvastatin (torcetrapib; atorvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Mixed Hyperlipidemia | Phase 3 | Status: TERMINATED